Æglea Biotherapeutics—founded by one of the most prolific researchers in the fields of chemical and biomedical engineering George Georgiou—is developing treatments for inborn errors of metabolism and therapies that target tumor metabolism from engineered human enzymes.
» Going to SXSW? Check out the SXSW 2015 Innovation Showcase and Reception
» Read the coverage by Silicon Hills News
Dr. Robert Langer joined UT Austin panelists Robert Metcalfe, Nicholas Peppas, and Dean Clay Johnston for a discussion on pursuing innovation. Widely known as the modern-day Thomas Edison, Langer has won over 220 major awards, holds more than 1,000 patents, and has launched various startups.
The Design Institute for Health is a collaboration between the new Dell Medical School and the College of Fine Arts at UT Austin to bring creative solutions to the health ecosystem.
Established by UT Austin chemistry professor Jonathan Sessler, Pharmacyclics was acquired to boost the cancer drug pipeline at AbbVie with what is expected to be one of the world's top-selling cancer therapeutic drugs.